All You Need to Know About Sabesp (SBS) Rating Upgrade to Buy

Sabesp (SBS) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Zacks Investment Research • 14 hours ago

SBS or AWR: Which Is the Better Value Stock Right Now?

Investors interested in Utility - Water Supply stocks are likely familiar with Sabesp (SBS) and American States Water (AWR). But which of these two stocks is more attractive to value investors?

Zacks Investment Research • Jun 1, 2026

Companhia de saneamento Basico Do Estado De Sao Paulo - Sabesp Q1 Earnings Call Highlights

Companhia de saneamento Basico Do Estado De Sao Paulo - Sabesp NYSE: SBS reported higher first-quarter 2026 revenue, EBITDA and net income, while management said the company continued to accelerate investments tied to its universal access commitments and operational transformation.

MarketBeat • May 15, 2026

SBS vs. AWR: Which Stock Is the Better Value Option?

Investors interested in Utility - Water Supply stocks are likely familiar with Sabesp (SBS) and American States Water (AWR). But which of these two stocks presents investors with the better value opportunity right now?

Zacks Investment Research • May 14, 2026

4 Stocks to Watch From the Challenging Water Supply Industry

Water utilities like SBS, AWR, AWK and CWT are supported by strategic capital investment plans and strong customer bases, positioning them to outperform peers despite persistent challenges facing the water industry.

Zacks Investment Research • May 12, 2026

Stratec Q1 Earnings Call Highlights

Stratec ETR: SBS reported a soft start to fiscal 2026, with first-quarter revenue and adjusted earnings down from the prior-year period, but management reaffirmed its full-year guidance and said visibility into second-half demand has improved.

MarketBeat • May 11, 2026

Companhia de Saneamento Básico do Estado de São Paulo - SABESP (SBS) Q1 2026 Earnings Call Transcript

Companhia de Saneamento Básico do Estado de São Paulo - SABESP (SBS) Q1 2026 Earnings Call Transcript

Seeking Alpha • May 12, 2026

Ironwood Pharmaceuticals to Share Real-World HCP Perspectives on Burden of Total Parenteral Nutrition in Short Bowel Syndrome (SBS) at Digestive Disease Week® 2026

BOSTON--(BUSINESS WIRE)--Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD), a biotechnology company developing and commercializing life-changing therapies for people living with gastrointestinal (GI) and rare diseases, announced today that the company will present data from its LANDMARK survey during the 2026 Digestive Disease Week® (DDW) meeting being held from May 2-5 in Chicago, IL. The data will spotlight healthcare professional (HCP) insights on the burden of total parenteral nutrition (TPN) f.

Business Wire • Apr 23, 2026

Stella Legal Unites with CSB, Strategic Business Solutions (SBS) To Build Mission Control for Modern Legal Departments

LONDON, NEW YORK & LISBON, Portugal--(BUSINESS WIRE)-- #LegalTech--Stella Legal and SBS unite to launch a tech-first operating model. It optimizes in-house legal departments via data-driven "Performance Intelligence.".

Business Wire • Apr 22, 2026

Sabesp: A New Privatization As An Opportunity!

Sabesp remains a buy, as its potential Copasa acquisition could be a game-changing catalyst, enhancing its investment thesis. SBS's privatization has driven significant efficiency gains, cost reductions, and a record-high EV/EBITDA multiple, reflecting strong management execution. Acquiring a 30% stake in Copasa would add nearly 10% to SBS's EBITDA, with further upside from operational synergies and a possible 27% valuation re-rating.

Seeking Alpha • Apr 11, 2026